Understand the source comparison
SS-LUP-332 and ERR Agonist Options: Research Application Comparison
Choosing the best SS-LUP-332 for ERR agonist research requires understanding how this compound fits within the broader landscape of metabolic modulators and mitochondrial enhancers. The table below compares SS-LUP-332 to related compounds used in metabolic res
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Choosing the best SS-LUP-332 for ERR agonist research requires understanding how this compound fits within the broader landscape of metabolic modulators and mitochondrial enhancers. The table below compares SS-LUP-332 to related compounds used in metabolic research, highlighting mechanism differences, selectivity profiles, and practical research considerations.
- SS-LUP-332 (SLU-PP-332)
- Direct ERRα/ERRγ agonist; activates mitochondrial biogenesis via PGC-1α upregulation
- Selective for ERRα and ERRγ; minimal ERRβ activity
- Mitochondrial function studies, metabolic syndrome models, endurance capacity assays, NAFLD research
- Lyophilized powder; store at −20°C; reconstitute with bacteriostatic water; use within 28 days at 2–8°C
- Best choice for isolating ERR-mediated mitochondrial biogenesis without off-target hormonal effects
- GW501516 (Cardarine)
- PPARδ agonist; increases fatty acid oxidation and glucose uptake in skeletal muscle
- Selective for PPARδ; no direct ERR activation
- Endurance research, lipid metabolism studies, insulin resistance models
- Stable at room temperature as powder; soluble in DMSO or ethanol; light-sensitive
- Strong metabolic effects but works through PPAR pathway, not direct mitochondrial transcription
- AICAR
- AMPK activator; mimics AMP to trigger energy-deficit signaling
- Non-selective; activates AMPK broadly across tissues
- Energy sensing studies, autophagy research, metabolic stress models
- Hygroscopic; store desiccated at −20°C; reconstitute fresh for each experiment
- Upstream activator with broad effects; less specific than ERR agonists for mitochondrial-targeted studies
- NAD+ Precursors (NMN, NR)
- Boosts NAD+ levels; indirectly supports SIRT1 and mitochondrial function
- Indirect; requires cellular conversion to NAD+
- Aging research, mitochondrial decline studies, sirtuin pathway investigations
- Store at −20°C; NMN particularly unstable in solution; use within 24 hours of reconstitution
- Supports mitochondrial health indirectly; slower onset than direct ERR agonists
- This comparison clarifies that SS-LUP-332 occupies a distinct niche: direct transcriptional activation of mitochondrial biogenesis genes without requiring upstream signaling or cofactor availability. PPARδ agonists like GW501516 enhance fatty acid metabolism but don't increase mitochondrial density as robustly. AMPK activators trigger energy-deficit responses that include mTOR inhibition and autophagy. Beneficial for some studies, confounding for others. NAD+ precursors depend on cellular conversion efficiency, which varies by tissue type and metabolic state. For research focused specifically on ERR-mediated pathways, SS-LUP-332 provides the cleanest experimental tool.